# Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

> clinical trial · VERIFIED · 2026-08-20

Status: SUSPENDED · Sponsor: Mayo Clinic · Condition: Castration-Resistant Prostate Carcinoma

- Company: Mayo Clinic
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT06200103

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.